RE:RE:RE:Glioblastoma market US$4.2 billion in 2028Bwah hahaha. Gobbledeegook, poof, copied, pasted, and undigested.
And yet all thos drugs like Herceptin that get a free ride because they require no R&D to speak of, will go to somebody else and Bioasis shareholders will lose any meaningful ownership in anything.
It's fun to watch you, though.
jd